Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xi'an
Clinical trial register · China

Clinical Trials in Xi'an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Beijing 5582 Shanghai 3880 Guangzhou 3354 Hangzhou 1824 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xijing Hospital123 Tang-Du Hospital50 First Affiliated Hospital Xi'an Jiaotong University41 Xijing Hospital of Digestive Diseases19 Air Force Military Medical University, China17
Site location
Beijing5582 Shanghai3880 Guangzhou3354 Hangzhou1824 Wuhan1342
All 625 locations
Target enrolment
to

Trials with a site in Xi'an

511 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Xi'an International Medical Center Hospital
Phase 4
462
Xi'an
2027-01
Not yet open
Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
Phase 1
88
Changsha, Xi'an, Shanghai, Huzhou
2026-11-15
Not yet open
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures
NCT07569575Tibial Fracture, Femoral Fracture, Humeral Fracture
HuaMg Perfection Med Tech (Suzhou) Co., Ltd.
Not applicable
160
Xicheng, Luoyang, Shijiazhuang, Xi'an, Xuhui
2026-11-01
Not yet open
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
NCT07725484Heart Failure Due to Coronary Artery Disease
DrugAlpha Lipoic Acid
Shanghai Zhongshan Hospital
Phase 3
1,188
Hefei, Fuzhou, Guangzhou, Luoyang, Zhengzhou, Nanjing, Dalian, Xi'an
2026-11-01
Not yet open
Xidian University
Not applicable
60
Xi'an
2026-11-01
Not yet open
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
40
Guangzhou, Xi’an
2026-11
Not yet open
EEG Feedback-Based Vagus Nerve Stimulation for Post-Stroke Dysphagia
NCT07894315Ischemic Stroke, Post-stroke Dysphagia, Swallowing Disorders
First Affiliated Hospital of Fujian Medical University
Not applicable
60
Fuzhou, Zhangzhou, Zhengzhou, Xi'an, Beijing
2026-11
Not yet open
Xiamen Amoytop Biotech Co., Ltd.
Phase 1
24
Beijing, Shanghai, Xi'an, Xiamen
2026-10-31
Recruiting
Eye Movement Intervention With Different Memory Reactivation Procedures for Intrusive Traumatic Memories
NCT07767396Post-traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s)
Shaanxi Normal University
Not applicable
117
Xi'an
2026-10-30
Recruiting
Takeda
Phase 2
36
Beijing, Guangdong, Nanning, Wuhan, Xi'an, Jinan, Chengdu, Hangzhou
2026-10-27
Recruiting
Qilu Hospital of Shandong University
Observational
100
Jinan, Xi’an, Hangzhou, Chongqing
2026-10-15
Recruiting
Pulsed Field Ablation for Ventricular Arrhythmias
NCT07727330Ventricular Arrhythmias
Xi'an Jiaotong University
Not applicable
30
Xi'an
2026-10-13
Not yet open
Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy
NCT07852416Liver Cirrhosis, Hepatic Encephalopathy, Minimal Hepatic Encephalopathy
The First Affiliated Hospital with Nanjing Medical University
Not applicable
80
Nanjing, Xi’an
2026-10-01
Recruiting
Yongquan Shi
Phase 4
448
Zhengzhou, Xi'an, Wenzhou, Beijing, Chongqing, Foshan, Fujian, Guangzhou
2026-10-01
Not yet open
Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery
NCT07576517Older Patients, Surgery, Dexmedetomidine, Esketamine
DrugDex-Esk
Peking University First Hospital
Phase 4
1,996
Beijing, Fuzhou, Shenzhen, Xi'an, Hangzhou
2026-10
Not yet open
MRI-Based Neurodevelopmental Risk Stratification in Infants With White Matter Injury
NCT07860749Punctate White Matter Lesions, Neurodevelopmental Outcomes, Preterm Infants
First Affiliated Hospital Xi'an Jiaotong University
Observational
260
Xi'an, Ankang, Chengdu, Hangzhou, Lanzhou, Qinghai, Shanghai, Shijiazhuang
2026-10
Not yet open
Peking University First Hospital
Phase 4
1,996
Beijing, Fuzhou, Shenzhen, Xi'an, Hangzhou
2026-10
Not yet open
Transjugular Approach for Implantation of Active Fixation Leadless Pacemakers
NCT07802119Bradycardia, Heart Block, Sick Sinus Syndrome, Atrioventricular Block
Min Shen
Not applicable
15
Xi'an
2026-09-10
Not yet open
Shuangyue Liu
Not applicable
30
Hefei, Beijing, Nanjing, Xuzhou, Dalian, Shanghai, Xi’an, Chengdu
2026-09-07
Not yet open
Heated Humidified Oxygen in PACU Patients
NCT07778420Hypoxemia, Postoperative Complications, Anesthesia Recovery Period
Second Affiliated Hospital of Xi'an Jiaotong University
Not applicable
2,000
Luoyang, Xi'an, Xianyang, Chengdu
2026-09-01
Recruiting
Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS
NCT07799948Hepatic Encephalopathy, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Portal Hypertension, Liver Cirrhosis
Air Force Military Medical University, China
Not applicable
30
Xi'an
2026-09-01
Recruiting
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Shenyang, Xi'an, Jinan
2026-09
Recruiting
Post-Marketing Clinical Study of High-Pressure Cutting Balloon
NCT07835178Coronary Artery Disease, Calcification
BrosMed Medical Co., Ltd
Not applicable
280
Xi'an
2026-09
Not yet open
Beijing 302 Hospital
Not applicable
60
Jinan, Taiyuan, Xi'an
2026-09
Not yet open
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
48
Guangzhou, Nanchang, Shanghai, Wenzhou, Xi'an
2026-08-31
Recruiting
Xijing Hospital
Observational
100
Xi'an
2026-08-25
Not yet open
Tang-Du Hospital
Phase 2
15
Xi’an
2026-08-23
Active, closed
Xi'an Aerospace General Hospital
Phase 4
114
Xi'an
2026-08-15
Recruiting
Xijing Hospital
Observational
5,000
Zhaoqing, Xi'an, Jinan, Mianyang, Wuwei, Wuxi
2026-08-10
Recruiting
Xijing Hospital
Not applicable
500
Xi'an
2026-08-10
Recruiting
Xijing Hospital
Observational
5,000
Xi'an, Dalian, Hami, Heze, Jinan, Langfang, Liu‘an, Qingdao
2026-08-10
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
NCT07498335Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy
DrugAtrasentan
Novartis Pharmaceuticals
Phase 3
28
Beijing, Xi'an
2026-08-06
Recruiting
Xidian University
Not applicable
25
Xi'an
2026-08-06
Recruiting
Vifor Fresenius Medical Care Renal Pharma
Phase 2
18
Chengdu, Guangzhou, Hangzhou, Shanghai, Wuhan, Xi'an
2026-08-04
Recruiting
Xijing Hospital
Not applicable
24
Xi'an
2026-08-01
Recruiting
Xidian University
Not applicable
60
Xi'an
2026-08-01
Not yet open
Tang-Du Hospital
Observational
500
Xi’an
2026-07-15
Recruiting
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
NCT07518043Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)
DrugOpdivo
Shanghai Henlius Biotech
Phase 1
174
Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
2026-07-15
Not yet open
Tang-Du Hospital
Phase 2
50
Xi'an
2026-07-10
Recruiting
Neuregen Therapeutics Co., Ltd.
Phase 1
24
Shanghai, Wuhan, Xi'an
2026-07-09
Not yet open
Mesenteric Vein Access for OPVT-Related Recurrent Variceal Bleeding: An Ambispective Cohort
NCT07666256Occlusive Portal Vein Thrombosis (OPVT), Cavernous Transformation of Portal Vein, Gastroesophageal Varices Bleeding
Air Force Military Medical University, China
Not applicable
15
Xi'an
2026-07-01
Not yet open
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
NCT07667517Albuminuria, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Diseases
DrugFinerenone
First Affiliated Hospital of Zhejiang University
Phase 4
148
Chongqing, Fuzhou, Foshan, Guangzhou, Nantong, Suqian, Suzhou, Xi'an
2026-07-01
Not yet open
BeBetter Med Inc
Phase 2
120
Guangzhou, Xi’an, Tianjin
2026-07-01
Not yet open
Zishen Yutai Pill for Patients With Recurrent Implantation Failure
NCT07641088Recurrent Implantation Failure
Peking University Third Hospital
Not applicable
878
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Changsha, Nanjing, Xi'an
2026-07-01
Recruiting
Xijing Hospital
Phase 2
120
Xi'an
2026-07-01
Not yet open
Air Force Military Medical University, China
Observational
220
Xi'an
2026-07-01
Not yet open
Xijing Hospital
Not applicable
98
Xi'an
2026-07-01
Recruiting
Tang-Du Hospital
Not applicable
500
Xi'an
2026-07-01
Not yet open
The First Affiliated Hospital of Air Force Medical University
Phase 1/2
162
Xi’an
2026-07
Not yet open
Zhifeng Zhao, PhD
Phase 2
46
Xi'an
2026-07
Not yet open
Beijing Tongren Hospital
Phase 4
159
Beijing, Guangzhou, Shanghai, Xi'an, Zhongshan
2026-06-30
Not yet open
A Real-world HCM-cohort Trial
NCT07638033Hypertrophic Cardiomyopathy (HCM)
Xijing Hospital
Observational
3,000
Xi'an
2026-06-30
Recruiting
Bambusa Therapeutics
Phase 1/2
48
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jinzhou, Wuxi, Taiyuan, Xi’an
2026-06-29
By invitation
The First Affiliated Hospital of Air Force Medical University
Observational
1,000
Xi’an
2026-06-22
Recruiting
Xidian University
Not applicable
25
Xi'an
2026-06-21
Recruiting
West China Second University Hospital
Not applicable
62
Hefei, Nanning, Guiyang, Zunyi, Nanchang, Xi'an, Chengdu, Ürümqi
2026-06-19
By invitation
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xi’an
2026-06-18
Recruiting
Xidian University
Not applicable
30
Xi'an
2026-06-16
Recruiting
Xidian University
Not applicable
30
Xi'an
2026-06-16
Recruiting
Merz North America, Inc.
Not applicable
218
Beijing, Guangzhou, Nanjing, Xi'an, Shanghai
2026-06-15
Not yet open
Tang-Du Hospital
Not applicable
60
Xi'an
2026-06-15
Not yet open
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial
NCT07699770Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
DrugCrisugabalin
Tang-Du Hospital
Phase 4
110
Beijing, Chongqing, Harbin, Hohhot, Changchun, Shenyang, Xi'an, Ürümqi
2026-06-15
Not yet open
Zhengli Di
Not applicable
30
Xi'an
2026-06-15
Active, closed
Xi'an Jiaotong University
Not applicable
46
Xi'an
2026-06-11
Recruiting
A Digital Cognitive Intervention for Intrusive Memories After Trauma
NCT07523360Post-Traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s)
Zhu Zijian
Not applicable
123
Xi'an
2026-06-10
Recruiting
CASI pharmaceuticals, Inc.
Phase 1/2
58
Beijing, Guangzhou, Wuhan, Xi'an
2026-06-09
Recruiting
Fecal Microbiota Transplantation for the Treatment of Refractory Hepatic Encephalopathy After TIPS Surgery
NCT07683936Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS, Refractory Hepatic Encephalopathy
DrugsRifaximin、Lactulose·Fecal Microbiota Transplantation
Air Force Military Medical University, China
Early Phase 1
26
Xi'an
2026-06-01
Recruiting
Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma
NCT07652489Adenoid Cystic Carcinoma, Sinonasal Carcinoma
Eye & ENT Hospital of Fudan University
Observational
70
Harbin, Changsha, Shenyang, Shanghai, Xi’an, Wenzhou
2026-06-01
Not yet open
Surgical Robot or Static Guide for Dental Implant Placement
NCT07577245Partial Edentulism Class II
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
112
Xi’an, Shanghai
2026-06-01
Recruiting
Jie Liang
Not applicable
600
Beijing, Shenyang, Xining, Xi'an, Shanghai, Changzhi, Linfen, Yuncheng
2026-06-01
Not yet open
Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial
NCT07628777Heart Failure With Preserved Ejection Fraction (HFPEF), Chronic Heart Failure
DrugFecal Microbiota Transplantation (FMT)
The First Affiliated Hospital of Air Force Medical University
Phase 1/2
50
Xi’an
2026-06
Not yet open
Xijing Hospital
Observational
20
Xi'an
2026-05-31
Not yet open
Myomed Technology (Shaoxing) Co., Ltd.
Not applicable
20
Xi'an
2026-05-30
Not yet open
Tang-Du Hospital
Phase 2
33
Xi'an
2026-05-30
Not yet open
Biotech Pharmaceutical Co., Ltd.
Phase 1
60
Chongqing, Zhengzhou, Changsha, Nanjing, Xi'an, Shanghai, Taiyuan, Chengdu
2026-05-30
Recruiting
Xijing Hospital
Phase 2
34
Xi'an
2026-05-29
Recruiting
Tang-Du Hospital
Phase 2
60
Xi'an
2026-05-13
Recruiting
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
NCT07529626Pancreatic Tumor, Benign, Pancreatic Cancer, Adult, Pancreatic Cancer Resectable
Shanghai Zhongshan Hospital
Observational
320
Changsha, Shanghai, Xi’an
2026-05-11
Recruiting
Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis
NCT07587125Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis, Multiple Sclerosis (MS) Secondary Progressive, Refractory Multiple Sclerosis
Xijing Hospital
Phase 1
9
Xi'an
2026-05-08
Active, closed
Radar Sleep Monitoring in Type 1 Narcolepsy: Feasibility
NCT07654803Narcolepsy Type 1 (NT 1), Hypersomnolence Disorder
Xijing Hospital
Observational
1
Xi'an
2026-05-07
Recruiting
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)
NCT07316270AF - Atrial Fibrillation, Intracranial Hemorrhage, Spontaneous
Beijing Anzhen Hospital
Not applicable
646
Hefei, Beijing, Xiamen, Harbin, Changchun, Xi'an
2026-05-06
Recruiting
Tang-Du Hospital
Phase 2
90
Xi'an
2026-05-05
Active, closed
Xijing Hospital
Not applicable
240
Xi'an
2026-05-03
Not yet open
Tang-Du Hospital
Phase 1
30
Xi'an
2026-05-01
Not yet open
Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
NCT07535138Membranous Nephropathy, Lupus Nephritis (LN), IgA Nephropathy (IgAN)
Air Force Military Medical University, China
Early Phase 1
15
Xi'an
2026-05-01
Not yet open
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
NCT07550894Acute Kidney Injury, Sepsis, Critically Ill Patients Requiring Continuous Renal Replacement Therapy
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou, Nanning, Luoyang, Zhengzhou, Wuhan, Nanjing, Xi'an
2026-05-01
Not yet open
Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer
NCT07538193Carcinoma, Non-Small-Cell Lung (NSCLC), Neoplasm Staging, Lymphatic Metastasis
DrugIparomlimab and Tuvonralimab
Tang-Du Hospital
Not applicable
28
Xi'an
2026-05
Recruiting
Xijing Hospital of Digestive Diseases
Phase 4
226
Ankang, Hanzhong, Xi'an, Xianyang
2026-04-20
Recruiting
Transcutaneous Electrical Acupoint Stimulation at Jing-Well Points for Disorders of Consciousness
NCT07535593Disorders of Consciousness Due to Severe Brain Injury
Xijing Hospital
Phase 2/3
160
Xi'an
2026-04-20
Recruiting
Guangzhou Women and Children's Medical Center
Observational
1,050
Guangxi, Xi’an
2026-04-20
Recruiting
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1/2
40
Zhengzhou, Suzhou, Xi’an, Hangzhou
2026-04-16
Recruiting
Xuanwu Hospital, Beijing
Not applicable
264
Beijing, Fuzhou, Shijiazhuang, Harbin, Nanyang, Zhengzhou, Baotou, Xi'an
2026-04-15
Recruiting
Picankibart in Palmoplantar Pustulosis
NCT07552454Palmoplantar Pustulosis
DrugPicankibart
Xijing Hospital
Not applicable
60
Xi'an
2026-04-15
Not yet open
The Selective Intraperineural Nerve Root Block Study
NCT07531485Radiculopathy Lumbar, Radiculopathy Sacral, Radiculopathy Multiple Sites, Herniated Disc
Xi'an Honghui Hospital
Not applicable
80
Xi'an
2026-04-13
Recruiting
Tetris Intervention Following Subliminal Reactivation for Intrusive Memories
NCT07495917Post-traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s)
Shaanxi Normal University
Not applicable
106
Xi'an
2026-04-10
Recruiting
magAssist, Inc.
Not applicable
204
Beijing, Changsha, Guangzhou, Nanchang, Shanghai, Shenyang, Suzhou, Xi'an
2026-04-09
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Phase 3
820
Lanzhou, Shijiazhuang, Zhengzhou, Loudi, Dalian, Xining, Xi'an, Taiyuan
2026-04-07
Not yet open
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
100
Lanzhou, Xi'an, Tianjin
2026-04-01
Not yet open
Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo
NCT07519031Vitiligo, Mesenchymal Stem Cells, Exosomes
DrugsTacrolimus·Prednisone
Xijing Hospital
Phase 1/2
96
Xi'an
2026-04
Recruiting
Intra-arterial Methylprednisolone After Endovascular Thrombectomy
NCT07516522Ischemia Stroke, Thrombectomy, Large Vessel Occlusion
Tang-Du Hospital
Phase 2
210
Xi'an
2026-03-31
Recruiting
Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis
NCT07542652Gastric Carcinoma, Gastritis Chronic, Intestinal Metaplasia, Gastric Precancerous Lesions
Yongquan Shi
Observational
450
Xi'an
2026-03-31
Recruiting
Xijing Hospital
Not applicable
428
Xi'an
2026-03-30
Active, closed
ChunBao Li
Not applicable
270
Beijing, Shenzhen, Luoyang, Nanjing, Xi'an, Tai’an, Shanghai, Chengdu
2026-03-30
Recruiting
Xijing Hospital of Digestive Diseases
Phase 4
180
Xi’an
2026-03-26
Not yet open
Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer
NCT07466303Breast Cancer, Serplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer
DrugsTrastuzumab Rezetecan·Serplulimab
Xijing Hospital
Phase 2
84
Xi'an
2026-03-25
Recruiting
Tang-Du Hospital
Phase 1/2
20
Xi’an
2026-03-25
Recruiting
Amgen
Phase 3
406
Beijing, Zhengzhou, Changsha, Nanjing, Yinchuan, Xi'an, Jinan
2026-03-23
Recruiting
Yongquan Shi
Phase 4
46
Ankang, Hanzhong, Xi'an, Xianyang
2026-03-23
Recruiting
Universiti Sains Malaysia
Not applicable
30
Xi'an
2026-03-15
Recruiting
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
NCT07553754Prostate Cancer (Diagnosis), Bone Metastasis, PSMA PET, Liquid Biopsy
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Weinan, Xi'an, Xianyang, Xining, Yan’an
2026-03-12
Not yet open
Evaluation of the Outcome of Fecal Microbiota Transplantation
NCT07454408Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS
DrugsRifaximin、Lactulose·Fecal Microbiota Transplantation
Air Force Military Medical University, China
Phase 1/2
40
Xi’an
2026-03-07
Recruiting
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2026-03-03
Recruiting
Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time
NCT07401303Early Gastric Cancer or Gastric Adenoma
Xijing Hospital of Digestive Diseases
Not applicable
640
Xi'an
2026-03-01
Recruiting
Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults
NCT07339631Low Back Pain, Paraspinal Muscle, CLBP - Chronic Low Back Pain, Non-specific Chronic Low Back Pain
Xijing Hospital
Phase 1
40
Xi'an
2026-03-01
Recruiting
Factors for Prolonged Hospital Stays in Patients Undergoing ERCP
NCT07568626Post-ERCP Adverse Events, ERCP Complications
Air Force Military Medical University, China
Observational
504
Xiamen, Xi'an
2026-02-15
Recruiting
West China Second University Hospital
Not applicable
120
Chengdu, Guiyang, Hefei, Jiangxi, Kunming, Nanning, Ürümqi, Xi'an
2026-02-13
Recruiting
Eli Lilly and Company
Phase 2
450
Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi'an, Zhumadian
2026-02-10
Recruiting
Peking University People's Hospital
Phase 2
39
Beijing, Xi'an
2026-02-10
Recruiting
Xijing Hospital
Observational
180
Xi'an
2026-02-05
Recruiting
Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Low Back Pain (LBP) in Adults
NCT07368920Low Back Pain, Paraspinal Muscles, CLBP - Chronic Low Back Pain
Xijing Hospital
Not applicable
40
Xi'an
2026-02-01
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 2
111
Harbin, Hefei, Shanghai, Xi'an, Zhengzhou
2026-02-01
Not yet open
Tang-Du Hospital
Phase 3
390
Xi'an
2026-02-01
Active, closed
Xijing Hospital
Early Phase 1
1
Xi'an
2026-01-31
Recruiting
Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients
NCT07365345Transcatheter Aortic Valve Replacement (TAVR), Hemodynamic Stability, Anesthesia Induction, Electro-acupuncture
Air Force Military Medical University, China
Not applicable
150
Xi'an
2026-01-30
Recruiting
Tang-Du Hospital
Phase 1/2
45
Xi'an
2026-01-28
Active, closed
Time-Restricted Eating for Weight-Loss Maintenance
NCT07163455Overweight or Obese Adults
Harbin Medical University
Not applicable
500
Beijing, Chongqing, Shenzhen, Harbin, Xi'an, Qingdao, Weifang, Chengdu
2026-01-26
Recruiting
Tang-Du Hospital
Not applicable
192
Xi'an
2026-01-21
Active, closed
Janssen Research & Development, LLC
Phase 2
189
Beijing, Changsha, Chengde, Chengdu, Guangzhou, Sanmenxia, Wuxi, Xi'an
2026-01-20
Not yet open
Xijing Hospital
Not applicable
60
Xi'an
2026-01-20
Recruiting
Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy
NCT07365267Breast Cancer, Breast Reconstruction After Mastectomy, 3D-Printed Biodegradable Biological Mesh
Xijing Hospital
Not applicable
25
Xi'an
2026-01-15
Recruiting
Bristol-Myers Squibb
Observational
500
Beijing, Guangzhou, Jiazhuang, Zhengzhou, Suzhou, Changchun, Dalian, Xi'an
2026-01-15
Recruiting
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
120
Lanzhou, Qinhuangdao, Shenyang, Yinchuan, Xi’an
2026-01-07
Recruiting
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study
NCT07454070Depressive Disorder (Per DSM-V Criteria, Mild-to-moderate), Acute Coronary Syndrome (ACS), Percutaneous Coronary Intervention (PCI), Depressive Disorder
Jing Han
Not applicable
120
Xi'an
2026-01-06
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
364
Chongqing, Foshan, Zhengzhou, Wuhan, Shenyang, Guilin, Xi’an
2026-01-01
Active, closed
Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer
NCT07498400Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Cancer
Xijing Hospital
Not applicable
216
Xi'an
2026-01-01
Not yet open
Beijing Children's Hospital
Not applicable
2,650
Beijing, Chongqing, Guangzhou, Baoding, Zhengzhou, Wuxi, Changchun, Xi'an
2026-01-01
By invitation
Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices
NCT07352228Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol
DrugsCarvedilol·Propranolol
Xijing Hospital
Phase 4
350
Xi'an
2026-01-01
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
Recruiting
Air Force Military Medical University, China
Not applicable
26
Xi'an
2026-01-01
Recruiting
Song Hongping
Observational
340
Xi'an
2026-01-01
Recruiting
Tang-Du Hospital
Not applicable
174
Xi'an
2026-01-01
Not yet open
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
NCT07168291Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma ( FL), Burkitt Lymphoma
First Affiliated Hospital Xi'an Jiaotong University
Early Phase 1
3
Xi'an
2025-12-31
Recruiting
Shanghai Henlius Biotech
Early Phase 1
254
Shanghai, Xi'an
2025-12-29
By invitation
Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD
NCT07475052Inflammatory Bowel Disease, Heart Rate Variability, Biologics, Prediction
Xijing Hospital
Observational
100
Xi'an
2025-12-25
Not yet open
Xijing Hospital
Observational
125
Xi'an
2025-12-23
Recruiting
Anxiety and Depression in IBS: A Brain-Gut Axis Study
NCT07646834Irritable Bowel Syndrome (IBS), Anxiety, Depression
Tang-Du Hospital
Observational
200
Xi'an
2025-12-21
Recruiting
Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
NCT07022587De Novo Stenosis, Coronary Artery Disease
Xijing Hospital
Not applicable
2,000
Xi'an
2025-12-20
Recruiting
Akeso
Phase 2
90
Xi'an
2025-12-19
Recruiting
Xijing Hospital of Digestive Diseases
Phase 3
132
Guangzhou, Xi'an
2025-12-15
Recruiting
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT07127822Gastric / Gastroesophageal Junction Adenocarcinoma, MSI-H Cancer
DrugIparomlimab and Tuvonralimab
Peking University
Phase 2
106
Shijiazhuang, Harbin, Zhengzhou, Nanjing, Xi'an, Qingdao, Taiyuan, Chengdu
2025-12-15
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
36
Zhengzhou, Nanjing, Xuzhou, Shanghai, Xi’an
2025-12-10
Recruiting
Air Force Military Medical University, China
Phase 2
124
Xi'an
2025-12-10
Recruiting
Danyang Huichuang Medical Equipment Co., Ltd.
Phase 3
320
Beijing, Shijiazhuang, Baotou, Suzhou, Xi'an, Shanghai, Taiyuan, Tianjin
2025-12-10
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
42
Chongqing, Guangzhou, Chengde, Tangshan, Nanjing, Suzhou, Nanchang, Xi'an
2025-12-09
Recruiting
Tang-Du Hospital
Not applicable
12
Xi'an
2025-12-08
Recruiting
The First Affiliated Hospital of Air Force Medical University
Phase 1
5
Xi'an
2025-12-08
Recruiting
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Not applicable
792
Xi'an
2025-12-06
By invitation
Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas
NCT07448233Epilepsies, Remote Management of Epilepsy in Rural Areas
Xijing Hospital
Not applicable
20
Xi'an
2025-12-01
Not yet open
Xijing Hospital
Observational
1,630
Xi'an
2025-12-01
Recruiting
West China Hospital
Phase 4
232
Xi’an, Chengdu
2025-11-19
Recruiting
Xijing Hospital
Not applicable
3
Xi'an
2025-11-17
Recruiting
Sanofi
Observational
1,000
Beijing, Shenzhen, Changsha, Xi’an, Chengdu, Hangzhou, Ningbo, Chongqing
2025-11-17
Recruiting
Xijing Hospital
Phase 1
30
Xi'an
2025-11-06
Active, closed
Takeda
Phase 2
207
Wuhan, Xi'an, Shanghai, Kunming, Hangzhou
2025-11-03
Recruiting
Xijing Hospital
Observational
1,500
Xi'an
2025-10-31
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Phase 2
24
Xi'an
2025-10-30
Recruiting
A Study of Ivonescimab in First-Line ES-SCLC
NCT07245446Extensive-stage Small Cell Lung Cancer (ES-SCLC)
DrugsLigufalimab·Cadonilimab·Ivonescimab·Etoposide
Akeso
Phase 2
180
Beijing, Xi'an, Shanghai
2025-10-29
Recruiting
Yongquan Shi
Phase 4
1,248
Xi'an
2025-10-28
Recruiting
Novartis Pharmaceuticals
Phase 2
165
Beijing, Xi'an
2025-10-28
Recruiting
MAXVAX Biotechnology Limited Liability Company
Phase 3
25,000
Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha, Xi'an, Jinan, Chengdu
2025-10-22
Active, closed
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
203
Xi’an
2025-10-21
Recruiting
Air Force Military Medical University, China
Not applicable
648
Xi'an
2025-10-20
Recruiting
Desflurane vs. Propofol for Cardiac Anesthesia
NCT07116733Cardiac Surgery, Coronary Artery Bypass Grafting
Xijing Hospital
Phase 3
3,560
Fuzhou, Cangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nanjin, Xi'an, Chengdu
2025-10-20
Recruiting
Bristol-Myers Squibb
Phase 3
424
Beijing, Guangzhou, Baoding, Shijiazhuang, Changsha, Nanjing, Xi'an, Chengdu
2025-10-08
Recruiting
Xijing Hospital
Phase 1/2
20
Xi'an
2025-10-01
Not yet open
Yanbing Li
Observational
594
Hangzhou, Baoding, Beijing, Shanghai, Xi'an
2025-10-01
Recruiting
Xijing Hospital
Not applicable
60
Xi'an
2025-10-01
Not yet open
Yan Xue
Phase 4
40
Xi'an
2025-10-01
Recruiting
Xijing Hospital
Phase 2
34
Xi'an
2025-09-25
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Fuzhou, Guangzhou, Beijing, Guanzhou, Suzhou, Xi'an
2025-09-16
Not yet open
Multicenter Validation Study on Autism Screening Using a Machine-assisted System
NCT07006948Autism Spectrum Disorder, Early Developmental Impairment, Language Development Disorders
Children's Hospital of Fudan University
Observational
1,000
Hefei, Xiamen, Liuzhou, Harbin, Kunshan, Xi'an, Shanghai, Chengdu
2025-09-15
Recruiting
Chipscreen Biosciences, Ltd.
Phase 1/2
220
Beijing, Chengde, Shijiazhuang, Shiyan, Jinan, Taiyuan, Xi’an, Hangzhou
2025-09-08
Recruiting
Tang-Du Hospital
Observational
300
Xi'an
2025-09-01
Not yet open
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
NCT07156656Type A Aortic Dissection, Organ Failure, Multiple
DrugSivelestat sodium
Shanghai Zhongshan Hospital
Phase 4
236
Hefei, Fuzhou, Guangzhou, Shenzhen, Xi'an, Shanghai
2025-09-01
Not yet open
Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock
NCT07129031Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB)
Xijing Hospital
Phase 3
180
Xi'an
2025-09-01
Recruiting
Xijing Hospital of Digestive Diseases
Not applicable
100
Xi'an
2025-09-01
Not yet open
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 1/2
32
Shanghai, Xi'an
2025-08-31
Not yet open
Xijing Hospital
Observational
150
Xi'an
2025-08-31
Recruiting
Second Affiliated Hospital of Soochow University
Phase 4
580
Suzhou, Shijiazhuang, Zhoukou, Bayan Nur, Huai'an, Suqian, Taizhou, Xi'an
2025-08-30
Recruiting
Tang-Du Hospital
Phase 2
32
Xi'an
2025-08-25
Recruiting
Boston Scientific Corporation
Not applicable
1,616
Beijing, Beijin, Guangzhou, Wuhan, Xi'an
2025-08-21
Recruiting
Transcranial Alternating Current Stimulation for Refractory Constipation With Somatic Symptom Disorder
NCT07323407Functional Constipation (FC), Somatic Symptom Disorder (DSM-5), Refractory Constipation
Xijing Hospital of Digestive Diseases
Not applicable
60
Xi'an
2025-08-20
Recruiting
Study on the Preferences for PCI Implantation Devices Among Doctors and Patients
NCT07378163Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Recruiting
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients
NCT07378137Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Not yet open
Xijing Hospital
Not applicable
10
Xi'an
2025-08-15
Not yet open
Xijing Hospital
Not applicable
140
Xi'an
2025-08-15
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,150
Xi'an
2025-08-10
Recruiting
Tang-Du Hospital
Phase 3
1,060
Xi'an
2025-08-08
Recruiting
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
NCT07093411B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory
Beijing GoBroad Hospital
Early Phase 1
48
Hefei, Xi'an, Xuzhou
2025-08-05
Recruiting
Nutshell Therapeutics (Shanghai) Co., LTD.
Phase 1/2
220
Beijing, Guangzhou, Nanchang, Shanghai, Xi'an
2025-08-04
Recruiting
Xijing Hospital
Not applicable
60
Xi'an
2025-08-02
Recruiting
Xijing Hospital
Not applicable
15
Xi'an
2025-08-02
Not yet open
Sun Yat-sen University
Phase 2
66
Guangzhou, Xi'an
2025-08
Not yet open
Yang Fan, MD
Phase 2
164
Beijing, Changsha, Shanghai, Xi’an, Hangzhou
2025-07-31
By invitation
Xijing Hospital
Not applicable
354
Xi’an
2025-07-30
Recruiting
Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery
NCT06482749Older Patients, Cognitive Impairment, Repetitive Transcranial Magnetic Stimulation, Delayed Neurocognitive Recovery
Peking University First Hospital
Not applicable
568
Beijing, Shenzhen, Xi'an
2025-07-28
Recruiting
Bristol-Myers Squibb
Phase 3
450
Beijing, Guangzhou, Baoding, Changsha, Nanjing, Xi'an, Chengdu, Tianjin
2025-07-18
Active, closed
Xijing Hospital
Not applicable
120
Xi'an
2025-07-18
Recruiting
The First Affiliated Hospital of Air Force Medical University
Early Phase 1
3
Xi’an
2025-07-14
Recruiting
MITRIS China Post Market Clinical Follow-up (PMCF) Study
NCT07059793Mitral Valve Replacement
Edwards Lifesciences
Observational
250
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Nanjing, Xi'an, Jinan
2025-07-08
Recruiting
Rectal NSAIDs With/Without PD Stent for PEP Prevention
NCT07117318Post-ERCP Acute Pancreatitis, Non-steroid Anti-inflammatory Drugs, Pancreatic Duct Stent Placement
DrugNSAIDs
Air Force Military Medical University, China
Not applicable
1,278
Beijing, Chongqing, Xiamen, Harbin, Kaifeng, Wuhan, Changsha, Xi'an
2025-07-01
Recruiting
Orthodontic Treatment on Oral Microbiota and Salivary Proteins
NCT06824493Orthodontics, White Spot Lesions [Initial Caries] on Smooth Surface of Tooth, Caries, Dental
Xi'an Jiaotong University
Observational
150
Xi'an
2025-07-01
Recruiting
Xijing Hospital
Observational
200
Xi'an
2025-07-01
By invitation
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
NCT07023965Peripheral Arterial Disease(PAD), Arterial Occlusive Disease, Arteriosclerosis Obliterans, Thromboangiitis Obliterans
Beijing Northland Biotech. Co., Ltd.
Observational
542
Beijing, Chifeng, Dalian, Hangzhou, Xi'an
2025-06-30
Recruiting
Xijing Hospital
Not applicable
1,200
Xi'an
2025-06-20
Not yet open
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
NCT07014254Pancreatic Ductal Adenocarcinoma (PDAC), Adenocarcinoma of the Stomach, Colorectal Cancer Metastatic, Neuroendocrine Tumor (NET)
Xijing Hospital
Not applicable
20
Xi'an
2025-06-20
Recruiting
Pfizer
Phase 2
620
Beijing, Lanzhou, Guangzhou, Haikou, Shijiazhuang, Changsha, Changchun, Xi'an
2025-06-19
Recruiting
Zuoyi Jiao
Phase 3
454
Beijing, Fuzhou, Lanzhou, Zhejiang, Xi'an
2025-06-16
Not yet open
Xijing Hospital
Not applicable
69
Xi'an
2025-06-15
Recruiting
Xijing Hospital
Phase 2
27
Xi'an
2025-06-05
Recruiting
Study of ESG406 in Adults With Solid Tumors
NCT06979674Locally Advanced/Metastatic Solid Tumors
Shanghai Escugen Biotechnology Co., Ltd
Phase 1
556
Chongqing, Xi’an, Hangzhou
2025-06-04
Recruiting
Nanfang Hospital, Southern Medical University
Not applicable
1,624
Guangzhou, Shenzhen, Zhuhai, Xi’an, Hangzhou
2025-06-03
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Phase 3
224
Xi'an
2025-06-01
Recruiting
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT07267117Heart Valve Disease, Mitral Valve (MV) Regurgitation, Mitral Valve Disease, Mitral Valve Stenosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
10,000
Fuzhou, Wuhan, Changsha, Shenyang, Xi'an, Qingdao, Chengdu, Ürümqi
2025-06-01
Recruiting
Advanced Adenoma Detection With 3D Imaging Device During Colonoscopy
NCT06924489Colorectal Adenoma, Colorectal Polyps
Xijing Hospital of Digestive Diseases
Not applicable
1,566
Xi'an
2025-06-01
By invitation
Exploration and Establishment of an Early Warning System for Futile Reperfusion - A I S
NCT07045987Acute Ischemic Stroke (AIS), Endovascular Thrombectomy, Neurovascular Unit- Brain Lymphatic System
Xijing Hospital
Observational
2,000
Xi’an
2025-06-01
Recruiting
Xijing Hospital
Observational
150
Xi'an
2025-05-26
Recruiting
Xijing Hospital
Observational
300
Wuwei, Shantou, Zhaoqing, Zhengzhou, Xi'an, Yan’an, Taiyuan, Chengdu
2025-05-26
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Nanjing, Nanchang, Xi'an, Heze, Jinan
2025-05-26
Not yet open
Xijing Hospital
Observational
200
Xi'an
2025-05-25
Recruiting
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
NCT06702553Nitric Oxide, Cardiac Surgery, Cardiopulmonary Bypass, Adult Patients Undergoing Cardiovascular Surgery With Cardiopulmonary Bypass
Xijing Hospital
Phase 3
3,650
Xi'an
2025-05-19
Recruiting
Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury.
NCT07092423Traumatic Brain Injury, Neurocritical Care, Enteral Feeding Intolerance
Tang-Du Hospital
Not applicable
100
Xi'an
2025-05-18
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
290
Xi'an
2025-05-13
Recruiting
Jiangsu BioJeTay Biotechnology Co., Ltd.
Phase 1/2
56
Bengbu, Beijing, Tangshan, Zhengzhou, Nanchang, Xi’an, Tianjin
2025-05-12
Recruiting
Xijing Hospital
Early Phase 1
10
Xi'an
2025-05-01
Active, closed
Ting Chang, MD
Phase 1
10
Xi'an
2025-05-01
Recruiting
3D-printed Biodegradable Breast Implants for Breast Restoration
NCT06993714Breast Cancer, Breast Reconstruction
Xijing Hospital
Phase 2
120
Xi'an
2025-05-01
Not yet open
Tang-Du Hospital
Not applicable
20
Xi'an
2025-05
Active, closed
Xijing Hospital
Observational
800
Xi'an
2025-04-29
Recruiting
Xijing Hospital
Observational
450
Xi'an, Chengdu, Beijing, Shanghai
2025-04-24
Recruiting
BioNTech SE
Phase 1/2
380
Bengbu, Changchun, Chengdu, Chongqing, Huizhou, Nanning, Shanghai, Xi'an
2025-04-23
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
DrugsCeftolozane-tazobactam·Cefiderocol·Fosfomycin·Meropenem-Vaborbactam
National University of Singapore
Phase 4
600
Hangzhou, Xi'an, Xuzhou
2025-04-21
By invitation
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196Psoriasis (PsO), Randomised Controlled Trial
DrugSulodexide
Xijing Hospital
Phase 3
160
Xi'an
2025-04-20
Active, closed
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
NCT06900543Unresectable Hepatocellular Carcinoma
DrugSIRT
Chengdu New Radiomedicine Technology Co. LTD.
Phase 3
108
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Shenyang, Xi’an, Chengdu
2025-04-15
Recruiting
Transcranial Temporal Interference Stimulation In Severely Brain Injured Patients With Disorders of Consciousness
NCT06851156Disorders of Consciousness, Severe Brain Injury, Unresponsive Wakefulness Syndrome, Minimally Conscious State
Xijing Hospital
Not applicable
10
Xi'an
2025-04-07
Recruiting
Yongquan Shi
Phase 4
400
Xi'an
2025-04-01
Recruiting
Xijing Hospital
Not applicable
90
Xi'an
2025-04-01
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2025-04-01
Not yet open
A Study on the Safety and Functionality of the Implantable Wireless Brain-Computer Interfaces for Motor Rehabilitation
NCT06944834Quadriplegia, Amputations, Spinal Cord Injuries (SCI), Brainstem Stroke
Shanghai StairMed Technology Co., Ltd.
Not applicable
5
Xi'an
2025-04
Not yet open
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
NCT06914427Prostatic Neoplasms, Glioma, PARKINSON DISEASE (Disorder)
Xijing Hospital
Not applicable
35
Xi'an
2025-03-28
Not yet open
Long Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE
NCT06832813Drug-resistant Epilepsy, Transcranial Magnetic Stimulation
Xijing Hospital
Not applicable
100
Xi'an
2025-03-28
By invitation
Shaanxi Normal University
Not applicable
84
Xi'an
2025-03-19
Active, closed
Xijing Hospital
Not applicable
177
Xi'an
2025-03-18
Recruiting
The Effect of VitC on IVF Outcome of DOR Patients
NCT06794047Diminished Ovarian Reserve, IVF Outcomes
Peking University Third Hospital
Not applicable
1,100
Beijing, Shijiazhuang, Yinchuan, Xi’an, Shenzhen
2025-03-17
Active, closed
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
NCT07104201Primary Biliary Cholangitis (PBC)
DrugFenofibrate
Xijing Hospital of Digestive Diseases
Early Phase 1
15
Xi'an
2025-03-13
Recruiting
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
Active, closed
Xijing Hospital
Not applicable
99
Xi'an
2025-03-10
Active, closed
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores, AMR
DrugALXN2030
Alexion Pharmaceuticals, Inc.
Phase 2
47
Changsha, Guangzhou, Nanning, Shanghai, Wuhan, Xi'an
2025-03-07
Recruiting
The Feasibility of taVNS on Pregnancy Outcomes of Infertility Patients Undergoing IVF
NCT06742788Infertility Assisted Reproductive Technology
Xijing Hospital
Not applicable
90
Xi'an
2025-03-04
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
980
Zhengzhou, Changzhou, Nanjing, Suzhou, Xi’an
2025-03-01
Not yet open
Xijing Hospital
Not applicable
30
Xi'an
2025-03-01
By invitation
Coronary Arterial Microcirculation and Metabolism
NCT07074847Coronary Atherosclerosis of Native Coronary Artery
Shaanxi Provincial People's Hospital
Observational
100
Xi'an
2025-02-28
Recruiting
Yongquan Shi
Phase 4
400
Ankang, Tongchuan, Weinan, Xi'an, Xuchang, Yanan
2025-02-28
Recruiting
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study
NCT06896747Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions
DrugPlatelet rich plasma
Tang-Du Hospital
Phase 1/2
90
Xi'an
2025-02-21
Recruiting
Xijing Hospital
Not applicable
158
Xi'an
2025-02-20
Not yet open
Optimal LDL-C Target in High-risk Patients After PCI
NCT06821711Chronic Coronary Syndrome, Acute Coronary Syndromes, Percutaneous Coronary Intervention, High Risk Patient
Xijing Hospital
Not applicable
12,000
Xi'an
2025-02-20
Recruiting
IBSA Farmaceutici Italia Srl
Not applicable
500
Beijing, Changde, Chengdu, Shanghai, Xi'an
2025-02-19
Recruiting
Tang-Du Hospital
Phase 2
27
Changsha, Yinchuan, Xi'an
2025-02-18
Active, closed
Xijing Hospital
Not applicable
10
Xi'an
2025-02-10
Active, closed
Xijing Hospital
Not applicable
65
Xi'an
2025-02-10
Active, closed
AbbVie
Phase 3
468
Beijing, Guangzhou, Shijiazhuang, Wuhan, Suzhou, Xi'an, Taiyuan, Tianjin
2025-02-10
Active, closed
Genmab
Phase 3
584
Guangzhou, Xi'an, Changchun, Hanzhou, Shanghai, Tianjin, Zhengzhou
2025-02-07
Recruiting
Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome
NCT06722534Peutz-Jeghers Syndrome, Celecoxib, Small Bowel Polyp
DrugCelecoxib
Air Force Military Medical University, China
Not applicable
80
Xi'an
2025-02-01
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
NCT06798077Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
China-Japan Friendship Hospital
Observational
2,000
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Shenyang, Xi'an, Shanghai
2025-02-01
Not yet open
Evaluation of an Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy Without Invasive Procedures
NCT06762704The Focus is to Validate the Accuracy of a Non-invasive Artificial Intelligence Model for the Prediction of the Human Blastocyst Ploidy, Preimplantation Genetic Testing (PGT)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,408
Hefei, Nanjing, Nanchang, Xi'an, Shanghai
2025-02
Recruiting
AbbVie
Phase 2
150
Beijing, Fuzhou, Nanning, Harbin, Zhengzhou, Wuhan, Nanchang, Xi'an
2025-01-20
By invitation
First Affiliated Hospital Xi'an Jiaotong University
Early Phase 1
150
Xi'an
2025-01-15
Not yet open
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
NCT05694273Arrhythmia, Acute Cerebrovascular Disease
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2025-01-15
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
42
Xi'an
2025-01-10
Recruiting
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases （ACT-AD）
NCT06669182Alzheimer Disease, Transcranial Magnetic Stimulation, Cerebellum
Xijing Hospital
Not applicable
100
Xi'an
2025-01-07
Recruiting
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
NCT06613165Immune-related Adverse Event, Neoadjuvant Therapy, dMMR Colorectal Cancer
Xijing Hospital
Observational
100
Xi'an
2025-01-01
Recruiting
Xijing Hospital
Observational
146
Xi'an
2025-01-01
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2025-01-01
Recruiting
Second Affiliated Hospital of Xi'an Jiaotong University
Phase 3
400
Xi'an
2025-01-01
Not yet open
Xijing Hospital
Phase 2/3
340
Xi'an
2024-12-31
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
5,000
Xi'an
2024-12-31
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-12-31
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
4,000
Xi'an
2024-12-30
Recruiting
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1
30
Beijing, Xi'an
2024-12-26
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
150
Guangzhou, Shenzhen, Zhengzhou, Nanjing, Nanchang, Shanghai, Xi’an, Chengdu
2024-12-09
Not yet open
Changhai Hospital
Not applicable
204
Qinghai, Shanghai, Xi'an
2024-12-01
Recruiting
Wang Yusheng
Not applicable
146
Xi'an, Xianyang
2024-11-29
Recruiting
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NCT06684106Hyperlipidemia, Ursodeoxycholic Acid, Statin Therapy, Glucose Intolerance
DrugUDCA
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
128
Xi'an
2024-11-25
Active, closed
Xijing Hospital
Phase 2
116
Shijiazhuang, Xi'an, Tianjin
2024-11-15
Active, closed
AbbVie
Observational
110
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Dalian, Xi'an, Qingdao
2024-11-13
Recruiting
Yongquan Shi
Phase 4
196
Pingdingshan, Ankang, Hanzhong, Shangluo, Xi'an
2024-11-12
Active, closed
Xijing Hospital of Digestive Diseases
Phase 4
208
Xi'an
2024-11-11
Active, closed
Second Affiliated Hospital of Xi'an Jiaotong University
Not applicable
25
Xi’an
2024-11-01
Recruiting
Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia
NCT06756139Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug
Air Force Military Medical University, China
Not applicable
88
Haikou, Xi'an, Mianyang
2024-11-01
Not yet open
Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging
NCT06681155Coronary Arterial Disease (CAD), Acute Coronary Syndromes
Chinese PLA General Hospital
Observational
500
Shenzhen, Wuhan, Changchun, Xi'an, Ürümqi, Hangzhou, Beijing
2024-11
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-10-30
By invitation
Han Ying
Phase 2/3
244
Guangzhou, Xi'an
2024-10-30
Recruiting
Peking University People's Hospital
Observational
50
Beijing, Harbin, Nanjing, Shenyang, Xi'an
2024-10-26
Recruiting
Zhejiang University
Phase 1
58
Beijing, Xi’an, Hangzhou
2024-10-23
Active, closed
Servier
Phase 3
57
Shenzhen, Chengdu, Beijing, Shanghai, Xi'an
2024-10-18
Recruiting
Xijing Hospital
Not applicable
40
Xi'an
2024-10-18
Recruiting
Xijing Hospital
Phase 2
18
Xi'an
2024-10-16
Not yet open
Preoperative Risk Evaluation and Per ERAS Intervention in the Chinese Elderly Patients Underwent Spinal Fusion Surgery
NCT06607081Degenerative Spinal Disease, Elderly Patients, Spinal Fusion Acquired
Xijing Hospital
Not applicable
5,000
Xi'an
2024-10-15
Recruiting
Xiaoqin Luo
Not applicable
360
Xi'an
2024-10-10
Recruiting
Xi'an No.3 Hospital
Phase 1
18
Xi’an
2024-10-03
Recruiting
Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
NCT07180368Coronary Artery Disease, Diabete Mellitus, Chronic Kidney Disease, Hypertension
Xijing Hospital
Observational
2,000
Xi'an
2024-10-01
Recruiting
Tang-Du Hospital
Phase 2
80
Xi'an
2024-10-01
Recruiting
Yongquan Shi
Phase 2
150
Xi'an
2024-09-30
By invitation
Xijing Hospital of Digestive Diseases
Not applicable
44
Xi'an
2024-09-30
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Zhenjiang, Xi'an, Shanghai
2024-09-26
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
100
Beijing, Chongqing, Guangzhou, Wuhan, Xi’an, Chengdu, Hangzhou, Huzhou
2024-09-21
Recruiting
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Not applicable
858
Xi'an
2024-09-13
Active, closed
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 3
72
Beijing, Chongqing, Guangzhou, Changsha, Nanjing, Qingdao, Shanghai, Xi’an
2024-09-03
Recruiting
Tang-Du Hospital
Not applicable
96
Wuhan, Nanjing, Shenyang, Xi'an, Chengdu, Ürümqi, Chongqing, Shanghai
2024-09-01
By invitation
Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
NCT06712017Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable
GrandPharma (China) Co., Ltd.
Observational
100
Guangzhou, Jinan, Xi’an, Beijing, Shanghai
2024-08-22
Active, closed
Oneness Biotech Co., Ltd.
Phase 2/3
120
Jiangmen, Luoyang, Suzhou, Zhenjiang, Shenyang, Xi'an, Hangzhou, Guangzhou
2024-08-16
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
320
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Dalian, Jinan, Xi’an
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Hefei, Guangzhou, Shenzhen, Shijiazhuang, Changsha, Suzhou, Xi'an, Xianyang
2024-07-31
Recruiting
Intravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease
NCT06567938Coronary Artery Disease, Chronic Kidney Diseases
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,528
Xi'an
2024-07-25
Recruiting
Vigonvita Life Sciences
Phase 1
40
Beijing, Xi’an
2024-07-16
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
44
Xi'an
2024-07-15
Recruiting
Ting Chang, MD
Phase 1
9
Xi'an
2024-07-12
Recruiting
xiaohua li
Phase 2
118
Xi'an
2024-07-05
Recruiting
Tang-Du Hospital
Phase 2
104
Xi'an
2024-07-01
Recruiting
Xijing Hospital
Not applicable
80
Xi'an
2024-07-01
Not yet open
Tang-Du Hospital
Phase 2
178
Xi'an
2024-06-30
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
80
Xi'an
2024-06-27
Recruiting
Tang-Du Hospital
Phase 2
60
Xi'an
2024-06-20
Recruiting
Hangzhou Sumgen Biotech Co., Ltd.
Phase 3
360
Beijing, Guangzhou, Luoyang, Zhengzhou, Wuhan, Suzhou, Taiyuan, Xi’an
2024-06-14
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 2
30
Hangzhou, Harbin, Hefei, Jinhua, Nanchang, Shanghai, Ürümqi, Xi'an
2024-06-11
Recruiting
Exploring the Characteristics of Epileptogenic Foci in Drug-Resistant Epilepsy Based on Multimodal Imaging Technology
NCT06557720Drug Resistant Epilepsy, Magnetic Resonance Imaging, Electroencephalogram (EEG)
Xijing Hospital
Observational
50
Xi'an
2024-06-11
Recruiting
Shanghai RAAS Blood Products Co., Ltd.
Phase 1/2
76
Changsha, Hefei, Jinan, Lanzhou, Shanghai, Taiyuan, Tianjin, Xi'an
2024-05-31
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-05-09
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-05-09
Recruiting
Xi'an Jiaotong University
Phase 4
642
Xi'an
2024-05-06
Recruiting
Xijing Hospital
Phase 2
80
Xi’an
2024-05-01
Recruiting
Single-operator Versus Two-operator Technique in Single-balloon Enteroscopy
NCT06280469Single-balloon Enteroscopy, Operation
Shuhui Liang
Not applicable
228
Lanzhou, Zhuhai, Xi'an
2024-05-01
Active, closed
xiaohua li
Phase 2
36
Xi'an
2024-05-01
Recruiting
Tang-Du Hospital
Not applicable
60
Xi'an
2024-05-01
Recruiting
Efficacy of Acupuncture for the Treatment of Parkinson's Disease Related Constipation
NCT06390761Parkinson Disease, Constipation, Non-motor Symptom, Randomized Controlled Trial
Xi'an No.3 Hospital
Not applicable
60
Xi'an
2024-04-30
Recruiting
yilong Wang
Not applicable
134
Wuhu, Beijing, Tangshan, Xi'an, Tianjin
2024-04-22
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2024-04-09
Recruiting
pBFS Guided rTMS Over Cognitive Control Network for ASD
NCT06255535Autism Spectrum Disorder
Changping Laboratory
Not applicable
215
Fuzhou, Baoding, Xi'an, Jining, Linyi
2024-04-01
Recruiting
Xijing Hospital
Not applicable
71
Xi'an
2024-04-01
Recruiting
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
NCT06359808Colitis, Ulcerative, Sleep Quality, Gastrointestinal Microbiome, Autonomic Nervous System Imbalance
Xijing Hospital
Observational
152
Xi'an
2024-04-01
By invitation
Xijing Hospital
Not applicable
320
Shanghai, Xi'an
2024-03-28
Recruiting
Medtecx Co Ltd.
Not applicable
126
Hefei, Beijing, Wuhan, Nanjing, Nanchang, Xi'an, Shanghai, Tianjin
2024-03-26
Recruiting
Tang-Du Hospital
Phase 4
24
Xi'an
2024-03-15
Active, closed
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
NCT06257264Breast Cancer, Small Cell Lung Cancer, Ovarian Cancer, Gastric Cancer
DrugsBGB-43395·Fulvestrant
BeiGene
Phase 1
103
Beijing, Guangzhou, Harbin, Changsha, Shenyang, Xi'an
2024-03-11
Active, closed
Interventional Ventricular Assist System for PCI in CHIP Patients
NCT06373120High-Risk Percutaneous Coronary Intervention (High-risk PCI), Left Ventricular Assist Devices
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
262
Xi'an
2024-03-04
Recruiting
Daiichi Sankyo
Phase 2/3
860
Xi’an, Beijing, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanning
2024-02-27
Recruiting
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Not applicable
1,338
Xi'an
2024-02-27
Active, closed
Abbisko Therapeutics Co, Ltd
Phase 1
164
Hefei, Fuzhou, Xi'an, Harbin, Zhengzhou, Wuhan, Changsha, Nanchang
2024-02-22
Active, closed
Pfizer
Phase 1/2
71
Guangzhou, Wuhan, Xi'an
2024-02-19
Recruiting
Air Force Military Medical University, China
Phase 3
208
Xi'an
2024-02-01
Recruiting
Xijing Hospital of Digestive Diseases
Phase 3
150
Xi'an
2024-01-30
Recruiting
Xijing Hospital
Not applicable
40
Xi'an
2024-01-24
Recruiting
Xijing Hospital
Not applicable
96
Xi'an
2024-01-19
Recruiting
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
NCT06755151Primary Biliary Cholangitis (PBC)
DrugFenofibrate
Xijing Hospital of Digestive Diseases
Phase 3
300
Xi'an
2024-01-17
Recruiting
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
NCT06220617Colorectal Cancer, Adenomatous Polyps, Adenoma, Advanced Adenoma
Zhejiang University
Observational
3,600
Hangzhou, Guangzhou, Kunming, Nanjing, Xi'an, Zhengzhou
2024-01-11
Recruiting
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
NCT06199401Type A Aortic Dissection, Complication of Surgical Procedure, Aortic Diseases
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
680
Xi'an
2024-01-11
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
80
Xi'an
2024-01-06
Recruiting
Jin Lu, MD
Not applicable
41
Beijing, Nanjing, Qingdao, Xi’an
2024-01-05
Recruiting
Shanghai Xinzhi BioMed Co., Ltd.
Phase 2/3
55
Beijing, Guangzhou, Guiyang, Wuhan, Changsha, Suzhou, Xi’an, Chengde
2024-01-03
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
24
Xi'an, Hangzhou
2024-01-01
Recruiting
RenJi Hospital
Not applicable
1,200
Nanjing, Nanchang, Jinan, Shanghai, Xi’an, Tianjin, Hangzhou
2023-12-27
Recruiting
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1/2
110
Beijing, Hangzhou, Jinan, Shanghai, Shenyang, Wenzhou, Wuhan, Xi'an
2023-12-26
Active, closed
Beijing Chest Hospital
Phase 3
186
Beijing, Changsha, Hefei, Jiamusi, Shandong, Xi'an, Xinxiang, Shijiazhuang
2023-12-22
Active, closed
AbbVie
Phase 3
614
Beijing, Guangzhou, Wuhan, Xi'an, Jinan, Shanghai, Chengdu, Tianjin
2023-12-19
Active, closed
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
88
Chongqing, Xi'an
2023-12-07
Not yet open
Wen-hong Zhang
Observational
5,000
Hefei, Fuzhou, Wuhan, Nanjing, Xuzhou, Jinan, Taiyuan, Xi’an
2023-12-01
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicable
290
Beijing, Chongqing, Changsha, Nanjing, Suzhou, Shanghai, Xi’an, Chengdu
2023-12-01
Recruiting
Tang-Du Hospital
Phase 2
100
Xi'an
2023-11-24
Recruiting
Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting
NCT06141525Coronary Artery Bypass Grafting, Remote Ischemic Conditioning, Ischemia-Reperfusion Injury
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
648
Xi'an
2023-11-22
Recruiting
RenJi Hospital
Phase 2
22
Nanjing, Xi'an, Shanghai, Chengdu, Tianjin
2023-11-16
Recruiting
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
NCT06221722Constipation - Functional, Refractory Constipation, Fluoxetine, fMRI
DrugFluoxetine
Xijing Hospital of Digestive Diseases
Observational
150
Yinchuan, Xi'an
2023-11-01
Recruiting
Janssen Research & Development, LLC
Phase 1
355
Chongqing, Wenzhou, Xi'an
2023-11-01
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
100
Xi'an
2023-10-30
Recruiting
Xijing Hospital
Observational
3,000
Xi'an
2023-10-30
Recruiting
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
NCT06125847Homozygous Familial Hypercholesterolemia
First Affiliated Hospital Xi'an Jiaotong University
Early Phase 1
21
Xi'an
2023-10-29
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
40
Xi'an
2023-10-26
Recruiting
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1/2
63
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Yongzhou, Shenzhen, Xi’an
2023-10-17
Recruiting
AbbVie
Phase 3
1,500
Beijing, Chongqing, Guangzhou, Shenzhen, Wuhan, Nanchang, Changchun, Xi'an
2023-10-11
Recruiting
Tang-Du Hospital
Phase 2
20
Xi'an
2023-10-09
Recruiting
AbbVie
Phase 3
90
Chongqing, Suzhou, Xi'an, Shanghai, Hangzhou
2023-10-02
Recruiting
Xijing Hospital of Digestive Diseases
Not applicable
500
Xi'an
2023-10-01
Recruiting
Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
NCT06082531Platelets-rich Plasma, Osteoarthritis Knees Both, Meniscus Disorder, Cartilage Injury
DrugSodium Hyaluronate
Xijing Hospital
Not applicable
300
Xi'an
2023-09-01
Recruiting
Air Force Military Medical University, China
Phase 3
228
Xi'an
2023-09-01
Not yet open
Xi'an International Medical Center Hospital
Not applicable
20
Xi'an
2023-09
Active, closed
Cytokinetics
Phase 3
500
Guangzhou, Beijing, Jilin City, Nanjin, Shanghai, Shenyang, Wuhan, Xi'an
2023-08-31
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-08-25
Active, closed
Han Ying
Phase 2/3
184
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Yan’an, Kunming, Beijing
2023-08-21
Active, closed
Amgen
Phase 4
36
Beijing, Fuzhou, Guangzhou, Harbin, Xi'an, Hangzhou
2023-08-17
Recruiting
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric
NCT05956847Gastric Cancer, Precancerous Lesion of Digestive Tract, Extrachromosomal DNA
Xijing Hospital
Observational
1,000
Xi'an
2023-08-10
Active, closed
Pfizer
Phase 3
59
Beijing, Guangzhou, Wuhan, Xi'an
2023-08-09
Recruiting
Xijing Hospital
Not applicable
15
Xi'an
2023-07-20
Recruiting
Xijing Hospital
Not applicable
4,220
Xi'an
2023-07-06
Recruiting
Peking Union Medical College Hospital
Observational
336
Foshan, Guangzhou, Changsha, Wuxi, Jinan, Xi’an, Chengdu, Ürümqi
2023-06-29
Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT05797168Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
DrugsPalacaparib·Torvutatug samrotecan·Saruparib·Paraplatin
AstraZeneca
Phase 1/2
622
Chengdu, Chongqing, Guangzhou, Jinan, Xi'an, Zhengzhou
2023-06-05
Recruiting
Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke
NCT05561088Acupuncture, Acute Ischemic Stroke, Mechanical Thrombectomy
Xi'an No.3 Hospital
Not applicable
272
Xi'an
2023-04-27
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-04-23
Recruiting
Xijing Hospital
Phase 2
194
Xi'an
2023-04-03
Active, closed
fMRI Study of the Neural Mechanism of rTMS in the Treatment of Nicotine Dependence
NCT06762535Tobacco Use Disorder, Repetitive Transcranial Magnetic Stimulation
Tang-Du Hospital
Not applicable
50
Xi'an
2023-04-01
Active, closed
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
219
Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Nanjing, Shenyang, Xi'an
2023-03-09
Active, closed
Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)
NCT05512910Ischemic Stroke, Acute, Minocycline, Endovascular Treatment, Basilar Artery Occlusion
DrugMinocycline
Xijing Hospital
Phase 4
90
Xi'an
2023-03-04
Recruiting
Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis
NCT05786313Cervical Spinal Stenosis, Cervical Spinal Cord Injury, Individuation, Standardization
Xijing Hospital
Not applicable
500
Xi'an
2023-03-01
Recruiting
Xijing Hospital of Digestive Diseases
Phase 3
150
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Chengdu, Tianjin
2023-02-22
Recruiting
Xijing Hospital of Digestive Diseases
Phase 2/3
104
Beijing, Guangzhou, Zhengzhou, Changsha, Nanjing, Shenyang, Xi'an, Yan’an
2023-02-17
Active, closed
Klus Pharma Inc.
Phase 2
240
Guangzhou, Nanning, Wuhan, Changsha, Changchun, Dalian, Weifang, Xi’an
2023-01-17
Not yet open
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
NCT05681403Lymphoma, Autologous Hematopoietic Stem Cell Transplantation
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
53
Xi'an
2023-01-15
Recruiting
Eli Lilly and Company
Phase 1
677
Beijing, Guangdong, Hangzhou, Shanghai, Tianjin, Xi'an
2023-01-12
Active, closed
Tang-Du Hospital
Phase 2
40
Xi'an
2023-01-10
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an, Ankang, Changsha, Hanzhong, Jinan, Lanzhou, Weinan, Xianyang
2023-01-06
Recruiting
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
40
Xi'an
2023-01-05
Recruiting
Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical Surgery
NCT05895968Cervical Spinal Stenosis, Posterior Cervical Spine Surgery, Barbed Suture
Xijing Hospital
Not applicable
60
Xi'an
2023-01-01
Recruiting
Xijing Hospital
Not applicable
500
Xi'an
2023-01-01
By invitation
Xiaolong Yan, Dr.
Not applicable
660
Xi'an
2023-01-01
Recruiting
Tang-Du Hospital
Observational
300
Xi'an
2023-01-01
Active, closed
Xijing Hospital
Phase 2
31
Xi'an
2022-12-05
Recruiting
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
NCT06001073Coronary Artery Disease, Arrhythmias, Cardiac, Heart Valve Diseases, Aortic Dissection
First Affiliated Hospital Xi'an Jiaotong University
Observational
25,000
Xi'an
2022-12-05
Active, closed
To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse
NCT07730619Plaque Psoriasis, Biologic Agents, Relapse, Influence Factors
First Affiliated Hospital Xi'an Jiaotong University
Observational
140
Xi'an
2022-12-01
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2022-11-10
By invitation
Peking University International Hospital
Phase 4
102
Beijing, Qingdao, Shanghai, Xi’an
2022-11-01
Not yet open
Xijing Hospital
Phase 1/2
48
Xi'an
2022-09-30
Recruiting
LAAO Versus NOAC in Patients with AF and PCI
NCT05353140Atrial Fibrillation, Percutaneous Coronary Intervention
DrugsRivaroxaban·Clopidogrel·Aspirin
Xijing Hospital
Not applicable
1,386
Xi'an
2022-09-01
Recruiting
Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
NCT06006650Neoadjuvent, PD-1 Inhibitor, Chemotherapy, Esophageal Squamous Cell Carcinoma
Tang-Du Hospital
Phase 2
114
Xi'an, Xi’an
2022-08-01
Active, closed
Tang-Du Hospital
Not applicable
30
Xi'an
2022-08-01
Recruiting
Tang-Du Hospital
Phase 2
64
Beijing, Changsha, Xi'an, Shanghai, Chengdu, Tianjin
2022-07-21
Recruiting
Fudan University
Observational
385
Hefei, Shijiazhuang, Zhengzhou, Nantong, Taishing, Taizhou, Xi'an, Tianjin
2022-07-18
Active, closed
INSPIRIS China PMCF Study
NCT05404880Aortic Valve Replacement
Edwards Lifesciences
Observational
255
Beijing, Xiamen, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Xi'an, Chengdu
2022-07-13
Recruiting
Sun Yat-sen University
Phase 3
766
Chongqing, Guangzhou, Hengyang, Shenyang, Xi'an, Nanchong
2022-07-05
Recruiting
Ofatumumab in AQP4-IgG Seropositive NMOSD
NCT05504694Neuromyelitis Optica Spectrum Disorder
DrugOfatumumab
Tang-Du Hospital
Phase 1/2
5
Xi'an
2022-06-28
Active, closed
Celgene
Phase 3
939
Changsha, Nanchang, Xi'an, Shanghai, Taiyuan, Wenzhou, Beijing, Changchun
2022-06-23
Recruiting
Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an
NCT05424978Acute Ischemic Stroke, Thrombolysis, Endovascular Treatment
Xi'an No.3 Hospital
Observational
3,600
Xi'an
2022-06-01
Recruiting
Assessment of Brain Cognitive Impairment in Breast Cancer
NCT05305092Breast Cancer, Chemo-brain, Endocrine Therapy
Tang-Du Hospital
Observational
90
Xi'an
2022-05-31
Active, closed
xiaohua li
Observational
176
Xi'an
2022-05-22
Recruiting
Xijing Hospital
Not applicable
1,060
Xi'an
2022-05-16
Recruiting
Actelion
Phase 3
280
Beijing, Changsha, Nanjing, Qingdao, Shanghai, Xi'an
2022-05-04
Recruiting
Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction
NCT05356520Siewert Type II Adenocarcinoma of Esophagogastric Junction
Xijing Hospital of Digestive Diseases
Not applicable
212
Xi'an
2022-05-01
By invitation
AstraZeneca
Phase 3
214
Beijing, Changsha, Hangzhou, Nanjing, Shanghai, Shenyang, Wenzhou, Xi'an
2022-04-19
Recruiting
Shanghai Pharmaceuticals Holding Co., Ltd
Early Phase 1
45
Beijing, Taiyuan, Xi’an, Tianjin
2022-04-07
Active, closed
STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation
NCT05352074Slow Transit Constipation, Surgery
Third Military Medical University
Not applicable
252
Yuzhong, Lanzhou, Wuhan, Nanjing, Shengyang, Qingdao, Pudong, Xi’an
2022-03-27
Recruiting
Janssen Research & Development, LLC
Phase 4
295
Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Nanjing, Shanghai, Xi'an
2022-03-09
Recruiting
Xijing Hospital
Observational
3,000
Ankang, Hanzhong, Xi'an, Ya'an, Yunlin, Xianyang, Yan’an
2022-03-01
Recruiting
Changhai Hospital
Not applicable
150
Beijing, Guangzhou, Wuhan, Xi'an, Shanghai, Chengdu, Hangzhou
2022-03-01
Recruiting
Air Force Military Medical University, China
Observational
50
Xi’an
2022-02-09
Active, closed
China S3 PMS: SAPIEN 3 China Post Market Registry Study
NCT05168826Aortic Stenosis, Severe
Edwards Lifesciences
Observational
250
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Changsha, Shanghai, Xi’an
2022-01-24
Active, closed
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
176
Chongqicun, Fuzhou, Guangzhou, Changsha, Nanchang, Changchun, Jinan, Xi’an
2022-01-04
Recruiting
Xingshun Qi
Observational
3,000
Beijing, Fuzhou, Wuhan, Nanchang, Dalian, Shenyang, Xi'an, Jinan
2022-01-01
Active, closed
Eli Lilly and Company
Phase 3
152
Beijing, Fuzhou, Guangzhou, Harbin, Changsha, Changchun, Xi'an, Jinan
2021-12-20
Not yet open
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
NCT05043181Familial Hypercholesterolemia
Tang-Du Hospital
Phase 1
30
Xi'an
2021-12
Active, closed
1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
NCT04971356Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon
Xijing Hospital
Not applicable
1,948
Xi'an
2021-11-01
Active, closed
Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament
NCT04968028Ossification of Posterior Longitudinal Ligament, Cervical Spondylosis With Myelopathy
Shanghai Changzheng Hospital
Not applicable
167
Beijing, Shenzhen, Harbin, Jining, Qingdao, Shanghai, Taiyuan, Xi’an
2021-08-17
Active, closed
Hoffmann-La Roche
Phase 3
142
Hangzhou, Beijing, Chengdu, Fuzhou, Guangzhou, Shanghai, Wuhan, Xi'an
2021-06-25
Recruiting
68Ga-PSMA PET in the Renal Cell Carcinoma
NCT04987086Renal Cancer, Metastases, PSMA PET
Xijing Hospital
Not applicable
300
Lanzhou, Yinchuan, Xining, Xi'an, Weinan, Xianyang, Yan’an
2021-06-01
Recruiting
Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury
NCT04900168Moderate Traumatic Brain Injury
Tang-Du Hospital
Observational
1,000
Xi'an
2021-06-01
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Chengdu, Chongqing, Guangzhou, Harbin, Shanghai, Tianjin, Wuhan, Xi'an
2021-05-04
Not yet open
Neoadjuvant PDT in the Treatment of Cholangiocarcinoma
NCT04824742Cholangiocarcinoma Resectable
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
50
Xi'an
2021-04-01
Recruiting
Mi-thos® Transcatheter Mitral Valve Replacement Study
NCT04195984Mitral Valve Regurgitation
Shanghai NewMed Medical Co., Ltd.
Not applicable
122
Beijing, Shanghai, Xi’an
2021-03-25
Recruiting
Xijing Hospital
Observational
1,700
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
By invitation
Xijing Hospital
Not applicable
1,600
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
NCT07553780High-risk Prostate Cancer, PSMA PET, Treatment Response, Therapy Monitoring
Xijing Hospital
Observational
110
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-07
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
NCT07531329Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-05
Active, closed
Tang-Du Hospital
Phase 2
45
Xi'an
2021-03-01
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Beijing, Guangzhou, Hangzhou, Suzhou, Tianjin, Xi'an
2021-02-01
Active, closed
Xijing Hospital
Not applicable
2,272
Xi'an
2021-02-01
Active, closed
Hoffmann-La Roche
Phase 2
920
Beijing, Chengdu, Shanghai, Tianjin, Xi'an
2021-01-18
Active, closed
Amgen
Phase 1/2
181
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Suzhou, Qingdao, Xi’an
2021-01-04
Active, closed
Hoffmann-La Roche
Phase 2
303
Changchun, Guangzhou, Linyi, Nanchang, Shanghai, Tianjin, Wuhan, Xi'an
2020-11-27
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
DrugsPrifetrastat·Atirmociclib·Palbociclib·Letrozole
Pfizer
Phase 2
320
Beijing, Guangzhou, Changchun, Xi'an
2020-11-16
Recruiting
Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)
NCT06219083Cancer, Chemoradiotherapy, Nutrition, Healthy, Oncology
Xiaoqin Luo
Observational
1,538
Xi'an
2020-11-12
Recruiting
Abbott Vascular Medical Device Registry
NCT04573660Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism
Abbott Medical Devices
Observational
3,784
Xi'an, Jinhua, Ningbo
2020-10-25
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Beijing, Guiyang, Hunan, Jinan, Shanghai, Suzhou, Tianjin, Xi'an
2020-10-15
Recruiting
Assess the Risk of Cerebrovascular Disease
NCT04443439Cerebrovascular Disease
Tang-Du Hospital
Observational
100
Xi'an
2020-10-09
Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
NCT04557449Liposarcoma, Prostate Cancer, Advanced Breast Cancer, NSCLC (Non-small Cell Lung Cancer)
DrugAtirmociclib
Pfizer
Phase 1/2
430
Beijing, Zhengzhou, Wuhan, Xi’an, Hangzhou
2020-09-23
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Beijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Shenyang, Tianjin, Xi'an
2020-09-17
Active, closed
PharmaEssentia
Phase 3
174
Beijing, Chongqing, Guangzhou, Wuhan, Suzhou, Shenyang, Xi'an, Jinan
2020-08-25
Recruiting
Myocardialbridge Bypass Graft Surgery Efficacy Verification
NCT06857838Myocardial Bridge of Coronary Artery, Myocardial Bridge, Myocardial Bridging, Myocardial Infarction
Xi'an International Medical Center Hospital
Not applicable
500
Xi'an
2020-01-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
168
Beijing, Guangzhou, Changsha, Hohhot, Shanghai, Xi’an, Chengdu, Hanzhou
2020-01-01
Active, closed
Xijing Hospital
Not applicable
10
Xi'an
2019-12-01
Recruiting
Tang-Du Hospital
Observational
200
Xi'an
2019-11-04
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Tianjin, Xi'an, Hangzhou
2019-10-03
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Hefei, Beijing, Guangzhou, Harbin, Changsha, Nanjing, Changchun, Xi'an
2019-08-09
Recruiting
Beijing Hospital
Not applicable
115
Beijing, Guangzhou, Harbin, Nanjing, Xuzhou, Changchun, Xi'an, Luzhou
2019-07-02
Active, closed
LEO Pharma
Phase 2
131
Guangzhou, Hangzhou, Shanghai, Xi'an
2019-05-29
Active, closed
Università Vita-Salute San Raffaele
Not applicable
2,000
Xi'an
2019-04-15
Recruiting
Chinese University of Hong Kong
Phase 3
1,734
Xi'an, Shanghai, Tianjin, Hangzhou
2019-03-21
Recruiting
Xijing Hospital
Observational
668
Xi'an
2019-01-01
Recruiting
Xijing Hospital
Observational
500
Xi'an
2018-10-30
Active, closed
University Hospital Tuebingen
Phase 3
1,065
Xi'an
2018-07-27
Recruiting
Xi'an No.3 Hospital
Observational
30,000
Xi'an
2018-07-15
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
205
Xi'an
2018-06-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Tianjin, Beijing, Guangzhou, Changsha, Shanghai, Xi’an, Hangzhou, Ningbo
2018-04-24
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
200
Xi'an
2017-06-15
Rows per page Showing 1–500 of 511
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 511 of those studies with a site in Xi'an.

How many clinical trials are recruiting in Xi'an?

315 of the 511 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 95 have not yet opened recruitment, 81 are active but closed to new participants, and 20 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xi'an), 511 studies
PhaseStudiesRecruitingShare
Not applicable17310533.9%
Observational1127621.9%
Phase 2644012.5%
Phase 3532910.4%
Phase 431166.1%
Phase 129185.7%
Phase 1/227185.3%
Early Phase 11382.5%
Phase 2/3951.8%

Most active sponsors

Lead sponsors with the most studies (Xi'an)
Lead sponsorStudiesRecruiting
Xijing Hospital12376
Tang-Du Hospital5033
First Affiliated Hospital Xi'an Jiaotong University4126
Xijing Hospital of Digestive Diseases1916
Air Force Military Medical University, China1713
Yongquan Shi88
AbbVie63
Pfizer64
Xidian University65
Janssen Research & Development, LLC53
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.